Related references
Note: Only part of the references are listed.Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Lung Epithelial Cells Induce Both Phenotype Alteration and Senescence in Breast Cancer Cells
Masashi Furukawa et al.
PLOS ONE (2015)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
The Mitogen-activated Protein ( MAP) Kinases p38 and Extracellular Signal-regulated Kinase ( ERK) Are Involved in Hepatocyte-mediated Phenotypic Switching in Prostate Cancer Cells
Bo Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Clinical characteristics and prognostic factors of prostate cancer with liver metastases
HaiTao Wang et al.
TUMOR BIOLOGY (2014)
JAK/STAT signaling in hematological malignancies
W. Vainchenker et al.
ONCOGENE (2013)
Targeting tumor cell motility as a strategy against invasion and metastasis
Alan Wells et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
N. P. A. Devika Gunasinghe et al.
CANCER AND METASTASIS REVIEWS (2012)
Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance
Yvonne Chao et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
Magali Castells et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
Partial Mesenchymal to Epithelial Reverting Transition in Breast and Prostate Cancer Metastases
Yvonne Chao et al.
CANCER MICROENVIRONMENT (2012)
Metastatic Progression of Prostate Cancer and E-Cadherin Regulation by Zeb1 and Src Family Kinases
Aaron P. Putzke et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Pathways of chemotherapy resistance in castration-resistant prostate cancer
Kate L. Mahon et al.
ENDOCRINE-RELATED CANCER (2011)
Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis
Alan Wells et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Mechanism of the Mesenchymal-Epithelial Transition and Its Relationship with Metastatic Tumor Formation
Dianbo Yao et al.
MOLECULAR CANCER RESEARCH (2011)
The social aspects of EMT-MET plasticity
E. W. Thompson et al.
NATURE MEDICINE (2011)
Castration-Resistant Prostate Cancer Current and Emerging Treatment Strategies
Giuseppe Di Lorenzo et al.
DRUGS (2010)
Intercellular Transfer of Proteins as Identified by Stable Isotope Labeling of Amino Acids in Cell Culture
Ming Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
Yvonne L. Chao et al.
MOLECULAR CANCER (2010)
Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration
Bi-Sen Ding et al.
NATURE (2010)
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast et al.
NATURE MEDICINE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
Signal integration by JNK and p38 MAPK pathways in cancer development
Erwin F. Wagner et al.
NATURE REVIEWS CANCER (2009)
E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas
Alan Wells et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Epithelial-mesenchymal and mesenchymal - Epithelial transitions in carcinoma progression
Honor Hugo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
C. C. Yates et al.
BRITISH JOURNAL OF CANCER (2007)
Liver metastases in prostate carcinoma:: clinical characteristics and outcome
Damien Pouessel et al.
BJU INTERNATIONAL (2007)
Formation of E-cadherin-mediated cell-cell adhesion activates Akt and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells
P Reddy et al.
MOLECULAR ENDOCRINOLOGY (2005)
Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition?
EW Thompson et al.
CANCER RESEARCH (2005)
Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer
SJ Kim et al.
CANCER RESEARCH (2005)
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
RB Shah et al.
CANCER RESEARCH (2004)
Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin
AST Wong et al.
JOURNAL OF CELL BIOLOGY (2003)
E-cadherin expression in primary carcinomas of the breast and its distant metastases
PJ Kowalski et al.
BREAST CANCER RESEARCH (2003)
Treatment options in hormone-refractory prostate cancer - Current and future approaches
KA Harris et al.
DRUGS (2001)
Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation
S Pece et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
Share Paper
